CCL18 and intrahepatic cholangiocarcinoma: This decrease in CCL18 secretion results in the suppression of malignant behaviors in intrahepatic cholangiocarcinoma (ICC) cells, suggesting a promising therapeutic avenue (Zhou et al., 2024).